Published in Br J Addict on January 01, 1990
Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother (2009) 1.45
Jail management of arrestees/inmates enrolled in community methadone maintenance programs. J Urban Health (2004) 1.19
Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes? J Med Toxicol (2014) 0.81
Illicit opioid intoxication: diagnosis and treatment. Subst Abuse (2011) 0.77
Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia (2007) 2.52
Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up. Diabetes Care (2001) 2.45
Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ (1997) 2.33
Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia (2002) 2.23
Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry (2007) 2.03
Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia (1996) 1.70
Epidemiology: bridges over (and across) roaring levels. J Epidemiol Community Health (1998) 1.69
Pancreatitis and the risk of pancreatic cancer. Pancreas (1995) 1.64
Poverty, health services, and health status in rural America. Milbank Q (1988) 1.61
A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry (2003) 1.60
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol (2000) 1.55
Screening and prevention of diabetic blindness. Acta Ophthalmol Scand (2000) 1.51
Ethics of ignorance: lessons from the epidemiological assessment of the bovine spongioform encephalopathy ("mad cow disease") epidemic. Perspect Biol Med (1998) 1.51
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther (1999) 1.49
Success and failure at inpatient heroin detoxification. Br J Addict (1989) 1.48
[Vascular risk factors in patients with ischaemic stroke. Distribution according to age, sex and stroke subtype]. Rev Neurol (2008) 1.39
Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health (1998) 1.38
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care (2001) 1.38
Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet (1982) 1.35
Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract (2006) 1.26
Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer (1994) 1.25
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend (2001) 1.22
Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend (1994) 1.20
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology (Berl) (2004) 1.20
Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol (2008) 1.16
A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care (2000) 1.15
Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol (1992) 1.13
Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther (1993) 1.11
Detection and morphology of thymic remnants after video-assisted thoracoscopic extended thymectomy (VATET) in patients with myasthenia gravis. Int Surg (1996) 1.09
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Bone metabolism in type 2 diabetes mellitus. Acta Diabetol (1999) 1.08
Differential activation by Ca2+, ATP and caffeine of cardiac and skeletal muscle ryanodine receptors after block by Mg2+. J Membr Biol (2002) 1.07
Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia (1981) 1.07
Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol (2005) 1.06
Trends in pancreatic cancer mortality in Europe, 1955-1989. Int J Cancer (1994) 1.06
[Sabbatical leave, vacation or work?]. Med Clin (Barc) (1995) 1.06
Clinical assessment of dysphagia in early phases of Parkinson's disease. Neurol Sci (2002) 1.05
New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel. Eye (Lond) (2012) 1.04
Screening for antimicrobial activity of crude drug extracts and pure natural products from Mexican medicinal plants. J Ethnopharmacol (1992) 1.04
Video-assisted thoracoscopic extended thymectomy (VATET) in myasthenia gravis. Two-year follow-up in 101 patients and comparison with the transsternal approach. Ann N Y Acad Sci (1998) 1.03
Improvement in survival after myocardial infarction between 1978-85 and 1986-88 in the REGICOR study. (Registre GIroní del COR) registry. Eur Heart J (1995) 1.02
Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators. Int J Cancer (1997) 1.02
Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis (2005) 1.02
Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend (1987) 1.02
Cocaine abuse among heroin addicts in Spain. Drug Alcohol Depend (1991) 1.01
Cytokine stimulated endothelin release from endothelial cells. Life Sci (1991) 0.99
Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin. Antimicrob Agents Chemother (1982) 0.98
Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabet Med (2011) 0.98
Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts. Br J Addict (1991) 0.97
Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection. J Chromatogr B Biomed Sci Appl (1999) 0.97
A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes. Nutr Metab Cardiovasc Dis (2005) 0.97
Drug utilization studies: a tool for determining the effectiveness of drug use. Br J Clin Pharmacol (1983) 0.96
Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther (1997) 0.96
Sensation seeking amongst healthy volunteers participating in phase I clinical trials. Br J Clin Pharmacol (1995) 0.96
Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer. J Clin Epidemiol (1998) 0.95
Vascular abnormalities in diabetes and their treatment. Trans Ophthalmol Soc U K (1980) 0.95
Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes. Diabetologia (2003) 0.94
Causal thinking, biomarkers, and mechanisms of carcinogenesis. J Clin Epidemiol (1996) 0.94
Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects. Br J Addict (1992) 0.93
A randomised controlled clinical trial of nurse-, dietitian- and pedagogist-led Group Care for the management of Type 2 diabetes. J Endocrinol Invest (2008) 0.93
Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose. Diabetes Metab Res Rev (2004) 0.93
Circulating prostacyclin may be reduced in diabetes. Lancet (1980) 0.92
Myelodysplastic syndromes and malignant solid tumors: analysis of 21 cases. Am J Hematol (1992) 0.92
A randomized controlled trial comparing three invitation strategies in a breast cancer screening program. Prev Med (2001) 0.91
The role of insulin in beta 2-receptor mediated hypokalemia. Clin Endocrinol (Oxf) (1985) 0.91
Evaluation of the locus of control in patients with type 2 diabetes after long-term management by group care. Diabetes Metab (2006) 0.90
Human cancer, carcinogenic exposures and mutation spectra. Mutat Res (1999) 0.89
Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. II. Ventricular csf concentrations in acute brain post-traumatic syndromes. Eur Neurol (1975) 0.89
Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz. J Acquir Immune Defic Syndr (2001) 0.89
Carbohydrate counting improves coping ability and metabolic control in patients with Type 1 diabetes managed by Group Care. J Endocrinol Invest (2010) 0.89
Platelet shape change abnormalities in diabetic retinopathy. Diabetologia (1980) 0.88
Instrument for detection of delirium in general hospitals: adaptation of the confusion assessment method. Psychosomatics (2004) 0.88
Confounding by indication and past clinical trials. Epidemiology (1997) 0.88
Anxiety disorders in the joint hypermobility syndrome. Psychiatry Res (1993) 0.88
The locus of control in patients with Type 1 and Type 2 diabetes managed by individual and group care. Diabet Med (2008) 0.88
Association between joint hypermobility syndrome and panic disorder. Am J Psychiatry (1998) 0.88
Rating journals in health care administration. Med Care (1995) 0.87
Perceptions of diabetic retinopathy and screening procedures among diabetic people. Diabet Med (2002) 0.87
Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group. Ann Occup Hyg (2000) 0.87
Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators. J Clin Oncol (1995) 0.87
Implementing the Stockholm Treaty on Persistent Organic Pollutants. Occup Environ Med (2002) 0.86
Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake. J Endocrinol Invest (2009) 0.86
New phenylethanoids from Buddleja cordata subsp. cordata. Planta Med (2000) 0.85
DDT and pancreatic cancer. J Natl Cancer Inst (1993) 0.85
Finger-pricking devices: are they less painful than lancets? Diabet Med (1996) 0.85
Phytotoxicity and ultrastructural effects of gymnopusin from the orchid Maxillaria densa on duckweed (Lemna pausicostata) frond and root tissues. Phytochemistry (2002) 0.84
The structural properties of GaN/AlN core-shell nanocolumn heterostructures. Nanotechnology (2010) 0.84
Re: Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst (1994) 0.84
[The consumption of drugs in Spain and its position in European context]. Med Clin (Barc) (1993) 0.84
A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose. Diabetologia (2003) 0.84
A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol (2011) 0.84
Antibiotic prophylaxis with cefotaxime in gastroduodenal and biliary surgery. Am J Surg (1989) 0.83